Facilitating Access to Approved Medication
Get Access To Tildrakizumab-ASMN Injection
- API: tildrakizumab-asmn
- Packaging: injection
- Strength: Injection: 100 mg/mL solution in a single-dose prefilled syringe.
WHAT IS TILDRAKIZUMAB-ASMN AND WHAT IT IS USED FOR?
tildrakizumab-asmn is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
tildrakizumab-asmn is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
Tildrakizumab is a humanized IgG1/k monoclonal antibody that selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL-23 receptor. IL-23 is a naturally occurring cytokine that is involved in inflammatory and immune responses. Tildrakizumab inhibits the release of proinflammatory cytokines and chemokines. Active ingredient: tildrakizumab-asmn Inactive ingredients: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, sucrose, and Water for Injection, USP.
Note: (For Prescribing Information Approved Drugs, see)
- The Food and Drug Administration (FDA), USA.
- The European Medicines Agency (EMA).
All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. tildrakizumab-asmn injection is a pharmaceutical drug To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.